Price Alert

Centessa Pharmaceuticals (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

15.79

-0.12 (-0.75%)

At close: Sep 04, 2025, 3:59 PM

15.79

0.00%

After-hours: Sep 04, 2025, 04:36 PM EDT

-0.75% (1D)

Bid	14.74
Market Cap	2.11B
Revenue (ttm)	15.95M
Net Income (ttm)	-230.37M
EPS (ttm)	-1.85
PE Ratio (ttm)	-8.54
Forward PE	-10.01
Analyst	Buy

Ask	16
Volume	897,690
Avg. Volume (20D)	1,144,033
Open	15.81
Previous Close	15.91
Day's Range	15.56 - 16.13
52-Week Range	9.60 - 19.09
Beta	1.49

About CNTA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CNTA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CNTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Centessa Pharmaceuticals is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

5 months ago

-8.03%

Centessa Pharmaceuticals shares are trading lower ... Unlock content with Pro Subscription

News

2 months ago · zacks.com

Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock?

Centessa Pharmaceuticals (CNTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.